Guided Therapeutics

GTHP · OTC

$0.19+$0.03 (+18.75%)TodayMarket closed ·
Prev close $0.16

About GTHP

Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. The company is headquartered in Norcross, Georgia and currently employs 4 full-time employees. The firm is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.

Employees
4
Headquarters
Norcross, Georgia
Listed
Jul 1, 1997
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Guided Therapeutics executives
NameTitleSince
Michael James——
Mark Faupel—2001
Richard Blumberg——
Alan Grujic——
John Imhoff——

Revenue by product and region

Fiscal year ended Dec 31, 2019: $36.00K total revenue

By product

  • Devices$17.00K47.2%
  • Other$15.00K41.7%
  • Disposables$2.00K5.6%
  • Warranty$2.00K5.6%

By region

  • Asia$22.00K61.1%
  • Europe$14.00K38.9%

Similar companies

Companies in the same industry as Guided Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.